Almoosa Health Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,248	1,202	978.97	816.04	701.54	628.97
Revenue Growth (YoY)	27.50%	22.82%	19.97%	16.32%	11.54%	-
Cost of Revenue	859.6	834.02	674.5	587.73	486.9	408.79
Gross Profit	388.56	368.32	304.47	228.31	214.64	220.17
Selling, General & Admin	203.33	200.05	190.33	172.75	147.89	113.81
Other Operating Expenses	-18.9	-18.22	-13.82	-	-	-
Operating Expenses	188.39	186.23	180.44	172.75	147.89	113.81
Operating Income	200.18	182.09	124.03	55.56	66.75	106.36
Interest Expense	-69.68	-80.53	-22.59	-15.38	-3.82	-3.02
Earnings From Equity Investments	0.94	1.19	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	15.36	9.03	5.64
EBT Excluding Unusual Items	135.96	102.74	101.45	55.54	71.96	108.99
Gain (Loss) on Sale of Assets	0.08	0.11	0.33	0.03	-0.07	0
Asset Writedown	-	-	-	-0.01	-0.01	-0.55
Pretax Income	134.61	102.85	101.78	55.56	71.88	108.44
Income Tax Expense	2.79	8.43	3.63	4.54	9.46	3.67
Net Income	131.83	94.42	98.15	51.02	62.42	104.77
Net Income to Common	131.83	94.42	98.15	51.02	62.42	104.77
Net Income Growth	34.32%	-3.79%	92.38%	-18.27%	-40.42%	-
Shares Outstanding (Basic)	37	35	35	35	0	-
Shares Outstanding (Diluted)	37	35	35	35	0	-
Shares Change (YoY)	6.20%	-	-	34900.00%	-	-
EPS (Basic)	3.55	2.70	2.80	1.46	624.20	-
EPS (Diluted)	3.55	2.70	2.80	1.46	624.20	-
EPS Growth	26.47%	-3.79%	92.38%	-99.77%	-	-
Free Cash Flow	-87.4	-56.66	-343.12	-318.15	-120.76	-286.89
Free Cash Flow Per Share	-2.35	-1.62	-9.80	-9.09	-1207.55	-
Dividend Per Share	1.000	1.000	-	-	-	-
Gross Margin	31.13%	30.63%	31.10%	27.98%	30.59%	35.00%
Operating Margin	16.04%	15.14%	12.67%	6.81%	9.52%	16.91%
Profit Margin	10.56%	7.85%	10.03%	6.25%	8.90%	16.66%
Free Cash Flow Margin	-7.00%	-4.71%	-35.05%	-38.99%	-17.21%	-45.61%
EBITDA	277.04	257.04	182.72	105.45	88.99	129.3
EBITDA Margin	22.20%	21.38%	18.67%	12.92%	12.68%	20.56%
D&A For EBITDA	76.86	74.95	58.69	49.89	22.24	22.94
EBIT	200.18	182.09	124.03	55.56	66.75	106.36
EBIT Margin	16.04%	15.14%	12.67%	6.81%	9.52%	16.91%
Effective Tax Rate	2.07%	8.19%	3.57%	8.17%	13.16%	3.38%
Advertising Expenses	-	19.17	8.96	10.58	7.2	3.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.